Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ketamine | 6 | 2023 | 238 | 1.870 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 4 | 2023 | 106 | 1.270 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2023 | 77 | 1.040 |
Why?
|
| Depressive Disorder, Major | 3 | 2022 | 436 | 0.810 |
Why?
|
| Hearing Disorders | 3 | 2023 | 34 | 0.660 |
Why?
|
| Anxiety Disorders | 3 | 2023 | 725 | 0.660 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 220 | 0.630 |
Why?
|
| Anxiety | 1 | 2023 | 1240 | 0.530 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2022 | 265 | 0.470 |
Why?
|
| Veterans | 1 | 2020 | 1737 | 0.330 |
Why?
|
| Antidepressive Agents | 3 | 2023 | 335 | 0.260 |
Why?
|
| Depression | 4 | 2023 | 1730 | 0.250 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2023 | 22 | 0.220 |
Why?
|
| Electroencephalography | 3 | 2023 | 991 | 0.200 |
Why?
|
| Osteoarthritis, Hip | 1 | 2022 | 38 | 0.190 |
Why?
|
| Mood Disorders | 1 | 2023 | 163 | 0.190 |
Why?
|
| Suicide | 1 | 2023 | 188 | 0.190 |
Why?
|
| Parkinson Disease | 2 | 2018 | 688 | 0.190 |
Why?
|
| Quinolinic Acid | 1 | 2020 | 23 | 0.190 |
Why?
|
| Kynurenic Acid | 1 | 2020 | 26 | 0.190 |
Why?
|
| Kynurenine | 1 | 2020 | 67 | 0.180 |
Why?
|
| Quality of Life | 3 | 2023 | 4761 | 0.170 |
Why?
|
| Emotions | 1 | 2023 | 560 | 0.170 |
Why?
|
| Family | 1 | 2023 | 783 | 0.160 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 453 | 0.160 |
Why?
|
| Osteoarthritis, Knee | 1 | 2022 | 192 | 0.160 |
Why?
|
| Hallucinations | 1 | 2018 | 34 | 0.160 |
Why?
|
| Occipital Lobe | 1 | 2018 | 47 | 0.150 |
Why?
|
| Lewy Body Disease | 1 | 2018 | 19 | 0.150 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2019 | 264 | 0.150 |
Why?
|
| Brain | 3 | 2023 | 4208 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2018 | 279 | 0.140 |
Why?
|
| Humans | 19 | 2023 | 270740 | 0.120 |
Why?
|
| Precision Medicine | 1 | 2023 | 1207 | 0.120 |
Why?
|
| Infusions, Intravenous | 3 | 2022 | 1437 | 0.120 |
Why?
|
| Biomarkers | 2 | 2023 | 5051 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2023 | 33737 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 645 | 0.120 |
Why?
|
| Cognition | 1 | 2018 | 959 | 0.100 |
Why?
|
| Child | 5 | 2023 | 30559 | 0.100 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 818 | 0.090 |
Why?
|
| Adolescent | 4 | 2023 | 32767 | 0.090 |
Why?
|
| Psychometrics | 2 | 2023 | 973 | 0.080 |
Why?
|
| Female | 8 | 2023 | 148940 | 0.080 |
Why?
|
| Bayes Theorem | 2 | 2021 | 1060 | 0.070 |
Why?
|
| Parents | 2 | 2023 | 1082 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2021 | 2580 | 0.060 |
Why?
|
| Male | 7 | 2023 | 128315 | 0.060 |
Why?
|
| Family Relations | 1 | 2023 | 88 | 0.050 |
Why?
|
| Adult | 4 | 2023 | 82040 | 0.050 |
Why?
|
| Confidentiality | 1 | 2023 | 118 | 0.050 |
Why?
|
| Phenethylamines | 1 | 2021 | 14 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 400 | 0.050 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 214 | 0.050 |
Why?
|
| Random Allocation | 1 | 2021 | 741 | 0.040 |
Why?
|
| Syndrome | 1 | 2022 | 1407 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2022 | 276 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 787 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2018 | 57 | 0.040 |
Why?
|
| Mutation | 1 | 2019 | 15912 | 0.040 |
Why?
|
| Creatine | 1 | 2018 | 60 | 0.040 |
Why?
|
| Gray Matter | 1 | 2018 | 60 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2022 | 1016 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 652 | 0.040 |
Why?
|
| Animals | 1 | 2022 | 61956 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 831 | 0.030 |
Why?
|
| White Matter | 1 | 2018 | 190 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 606 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 2042 | 0.030 |
Why?
|
| Exercise | 1 | 2022 | 1184 | 0.030 |
Why?
|
| Pyridines | 1 | 2021 | 1313 | 0.030 |
Why?
|
| Oxygen | 1 | 2018 | 791 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2018 | 865 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2022 | 39890 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 2650 | 0.030 |
Why?
|
| Pain | 1 | 2022 | 1694 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1610 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 762 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1065 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 1690 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 5162 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 4831 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 30998 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 17888 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 13414 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 90352 | 0.010 |
Why?
|
| Aged | 2 | 2018 | 73333 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 7895 | 0.010 |
Why?
|